• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.

作者信息

Kiss T L, Chang H, Daly A, Messner H A, Jamal N, Spaner D, Rubin S, Lipton J H

机构信息

Department of Medical Oncology and Hematology, Princess Margaret Hospital/University Health Network, Toronto, Ontario, Canada.

出版信息

Bone Marrow Transplant. 2004 Apr;33(8):855-8. doi: 10.1038/sj.bmt.1704430.

DOI:10.1038/sj.bmt.1704430
PMID:14990983
Abstract

Pre transplant screening work-up of donors for allogeneic blood and marrow transplantation is essential in an effort to minimize risks to the recipient and protect the donor. At Princess Margaret Hospital, every potential donor is screened with a bone marrow aspirate. The case histories of three asymptomatic potential donors who presented within 1 year with normal complete blood counts, history and physical examination are presented. A 65-year-old male patient was diagnosed with smouldering multiple myeloma, a 72-year-old male patient with chronic lymphocytic leukemia and a 42-year-old male patient with myelodysplastic syndrome. Bone marrow examination led to the diagnosis in each one of these cases. Of note is that each of the potential donors was discovered to have the same disease as the transplant recipient. In vitro clonogenic hemopoietic progenitor assays were compared to those of 20 normal volunteers. Inferior growth of hemopoietic progenitor colonies in all three was noted. In conclusion, particularly in older donors and donors with potential for familial malignancies, more screening investigations including bone marrow aspiration may be reasonable to investigate for occult hematological malignancies prior to stem cell donation. Clonogenic assays can contribute to detect hemopoietic abnormalities pre transplant.

摘要

相似文献

1
Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.
Bone Marrow Transplant. 2004 Apr;33(8):855-8. doi: 10.1038/sj.bmt.1704430.
2
[Collection of hematopoietic progenitor cells from healthy donors].[从健康供体采集造血祖细胞]
Acta Med Croatica. 2009 Jun;63(3):237-44.
3
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
4
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.异基因干细胞移植治疗成人骨髓增生异常综合征:移植前疾病负担的重要性。
Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.
5
Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation.骨髓移植后供者和受者均发生多发性骨髓瘤。
Am J Hematol. 2002 Nov;71(3):227-8. doi: 10.1002/ajh.10239.
6
Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.异基因骨髓移植后受者和供者同时发生急性髓系白血病:1例报告并对供者评估的评论
Transfusion. 2009 Mar;49(3):555-62. doi: 10.1111/j.1537-2995.2008.02008.x. Epub 2008 Nov 26.
7
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.在异基因干细胞移植后,CD4+CD25+FOXP3+调节性T细胞在多发性骨髓瘤患者的骨髓中重建并积聚。
Haematologica. 2008 Mar;93(3):423-30. doi: 10.3324/haematol.11897. Epub 2008 Feb 20.
8
Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.血液系统恶性肿瘤患儿接受来自匹配无关供者的骨髓与外周血祖细胞移植后的长期生存情况比较。
Biol Blood Marrow Transplant. 2007 Nov;13(11):1338-45. doi: 10.1016/j.bbmt.2007.07.009. Epub 2007 Sep 21.
9
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.在接受造血生长因子的既往健康个体中发生的血液系统恶性肿瘤:药物不良事件及报告研究(RADAR)项目的报告
Br J Haematol. 2006 Dec;135(5):642-50. doi: 10.1111/j.1365-2141.2006.06312.x. Epub 2006 Oct 19.
10
Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor.异基因骨髓移植18年后,患者和供者同时出现骨髓增生异常综合征。
Bone Marrow Transplant. 2004 Apr;33(8):859-61. doi: 10.1038/sj.bmt.1704417.

引用本文的文献

1
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.相关异基因移植供体中的克隆性造血:对筛查和管理的启示
Biol Blood Marrow Transplant. 2020 Jun;26(6):e142-e144. doi: 10.1016/j.bbmt.2020.02.022. Epub 2020 Mar 5.
2
Sixty as the new forty: considerations on older related stem cell donors.六十当作新四十:关于老年相关干细胞供体的思考
Bone Marrow Transplant. 2017 Jan;52(1):15-19. doi: 10.1038/bmt.2016.201. Epub 2016 Aug 8.
3
Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities.
对骨髓供者进行有针对性的病理评估可发现以前未诊断的骨髓异常。
Biol Blood Marrow Transplant. 2013 Aug;19(8):1254-9. doi: 10.1016/j.bbmt.2013.05.022. Epub 2013 Jun 13.
4
Risks and mechanisms of oncological disease following stem cell transplantation.干细胞移植后肿瘤性疾病的风险和机制。
Stem Cell Rev Rep. 2010 Sep;6(3):411-24. doi: 10.1007/s12015-010-9134-5.
5
A novel chromosomal abnormality, t(6;10)(q27;q22), found in a polycythemic potential donor for allogeneic hematopoietic stem cell transplantation.在一名异基因造血干细胞移植的潜在红细胞增多症供者中发现了一种新的染色体异常,即t(6;10)(q27;q22) 。
Int J Hematol. 2005 Jul;82(1):72-4. doi: 10.1532/IJH97.05027.